prednisolone has been researched along with Familial Spastic Paraparesis, Htlv-1-Associated in 26 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Excerpt | Relevance | Reference |
---|---|---|
"Myositis is one of well-known complications of HTLV-1 associated myelopathy (HAM)." | 2.69 | [A study of clinical symptoms, muscle pathology, therapeutic response, and prognosis of myositis in patients with HTLV-1 associated myelopathy (HAM)]. ( Arimura, K; Higuchi, I; Hokezu, Y; Inose, M; Izumo, S; Osame, M; Yoshimine, K, 1999) |
"Fosfomycin could not suppress the HTLV-I-associated SP, but had the properties to decrease the levels of TGF-beta1 and MIP-1alpha." | 1.30 | Alteration of cytokine levels by fosfomycin and prednisolone in spontaneous proliferation of cultured lymphocytes from patients with HTLV-I-associated myelopathy (HAM/TSP). ( Arimura, K; Ijichi, S; Kawabata, M; Machigashira, K; Osame, M; Usuku, K; Yamano, Y, 1997) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (3.85) | 18.7374 |
1990's | 17 (65.38) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 6 (23.08) | 24.3611 |
2020's | 2 (7.69) | 2.80 |
Authors | Studies |
---|---|
Yamauchi, J | 2 |
Tanabe, K | 1 |
Sato, T | 3 |
Nakagawa, M | 4 |
Matsuura, E | 2 |
Tsuboi, Y | 1 |
Tamaki, K | 1 |
Sakima, H | 1 |
Ishihara, S | 1 |
Ohta, Y | 1 |
Matsumoto, N | 1 |
Kono, K | 1 |
Yagishita, N | 3 |
Araya, N | 3 |
Takahashi, K | 1 |
Kunitomo, Y | 1 |
Nagasaka, M | 2 |
Coler-Reilly, A | 2 |
Hasegawa, Y | 2 |
Araujo, A | 1 |
Jacobson, S | 1 |
Grassi, MFR | 1 |
Galvão-Castro, B | 1 |
Bland, M | 1 |
Taylor, GP | 2 |
Martin, F | 1 |
Yamano, Y | 4 |
Hasegawa, D | 1 |
Tsutsumi, S | 1 |
Inoue, E | 2 |
Takata, A | 1 |
Coler-Reilly, ALG | 1 |
Matsuzaki, T | 1 |
Niino, M | 1 |
Nagai, M | 2 |
Nakamura, T | 2 |
Takenouchi, N | 1 |
Gao, H | 1 |
Ye, X | 1 |
Cai, R | 1 |
Xu, Q | 1 |
Liang, L | 1 |
Izumo, S | 4 |
Xing, HQ | 1 |
Kubota, R | 2 |
Yoshimura, A | 1 |
Nozuma, S | 1 |
Higuchi, I | 3 |
Takashima, H | 2 |
Ando, R | 1 |
Nishikawa, N | 1 |
Tsujii, T | 1 |
Iwaki, H | 1 |
Yabe, H | 1 |
Nomoto, M | 1 |
Boostani, R | 1 |
Vakili, R | 1 |
Hosseiny, SS | 1 |
Shoeibi, A | 1 |
Fazeli, B | 1 |
Etemadi, MM | 1 |
Sabet, F | 1 |
Valizade, N | 1 |
Rezaee, SA | 1 |
Yamashita, S | 1 |
Ueda, A | 1 |
Hirahara, T | 1 |
Kimura, E | 1 |
Hirano, T | 1 |
Uchino, M | 1 |
Cartier, L | 1 |
Castillo, JL | 1 |
Cabrera, ME | 1 |
Araya, F | 1 |
Matutes, E | 1 |
Ford, AM | 1 |
Greaves, MF | 1 |
Ozawa, Y | 1 |
Migita, M | 1 |
Watanabe, T | 1 |
Okuda, I | 1 |
Takeshita, A | 1 |
Takagi, A | 1 |
Shishiba, Y | 1 |
Kuroda, Y | 1 |
Yukitake, M | 1 |
Kurohara, K | 1 |
Matsui, M | 1 |
Komaba, Y | 1 |
Kitamura, S | 1 |
Terashi, A | 1 |
Tamotsu, M | 1 |
Nakatani, Y | 1 |
Hara, A | 1 |
Osame, M | 9 |
Umehara, F | 1 |
Ijichi, S | 3 |
Moritoyo, T | 1 |
Usuku, K | 2 |
Arimura, K | 3 |
Machigashira, K | 1 |
Kawabata, M | 1 |
Inose, M | 1 |
Yoshimine, K | 1 |
Hokezu, Y | 1 |
Inui, T | 1 |
Kawai, H | 1 |
Adachi, K | 1 |
Saito, M | 1 |
Matsuka, Y | 1 |
Ikurou, M | 1 |
Kira, J | 1 |
Fujihara, K | 1 |
Itoyama, Y | 1 |
Goto, I | 1 |
Hasuo, K | 1 |
Matsuo, H | 1 |
Shibayama, K | 1 |
Motomura, M | 1 |
Nagasato, K | 1 |
Takeo, G | 1 |
Tsujihata, M | 1 |
Nagataki, S | 1 |
Ijichi, N | 1 |
Izumihara, T | 1 |
Niimura, T | 1 |
Igata, A | 1 |
2 reviews available for prednisolone and Familial Spastic Paraparesis, Htlv-1-Associated
Article | Year |
---|---|
Pathogenesis and treatment of HTLV-I associated myelopathy.
Topics: Adolescent; Adult; Anti-HIV Agents; Anti-Inflammatory Agents; Child; Child, Preschool; Female; Human | 1998 |
[HTLV-I-associated myelopathy].
Topics: Antiviral Agents; Diagnosis, Differential; Humans; Interferon-alpha; Paraparesis, Tropical Spastic; | 1999 |
3 trials available for prednisolone and Familial Spastic Paraparesis, Htlv-1-Associated
Article | Year |
---|---|
Efficacy of Corticosteroid Therapy for HTLV-1-Associated Myelopathy: A Randomized Controlled Trial (HAMLET-P).
Topics: Adrenal Cortex Hormones; Aged; Disabled Persons; Female; Human T-lymphotropic virus 1; Humans; Male; | 2022 |
A follow-up study on spastic paraparesis in Japanese HAM/TSP.
Topics: Adult; Aged; Anti-Inflammatory Agents; Cerebellar Ataxia; Disability Evaluation; Disease Progression | 1995 |
[A study of clinical symptoms, muscle pathology, therapeutic response, and prognosis of myositis in patients with HTLV-1 associated myelopathy (HAM)].
Topics: Adult; Aged; Anti-Inflammatory Agents; Atrophy; Female; Follow-Up Studies; Humans; Immunosuppressive | 1999 |
21 other studies available for prednisolone and Familial Spastic Paraparesis, Htlv-1-Associated
Article | Year |
---|---|
Use of cerebrospinal fluid CXCL10 and neopterin as biomarkers in HTLV-1-associated myelopathy/tropical spastic paraparesis treated with steroids.
Topics: Biomarkers; Chemokine CXCL10; Glucocorticoids; Human T-lymphotropic virus 1; Humans; Neopterin; Para | 2020 |
Effectiveness of Daily Prednisolone to Slow Progression of Human T-Lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis: A Multicenter Retrospective Cohort Study.
Topics: Aged; Cohort Studies; Disease Progression; Female; Glucocorticoids; Humans; Male; Middle Aged; Parap | 2017 |
Multiple spotty lesions of the spinal cord in a Chinese patient with human T-lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis.
Topics: Administration, Intravenous; Administration, Oral; Antibodies, Viral; Asian People; China; Female; H | 2018 |
Clinical presentation of axial myopathy in two siblings with HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Topics: Aged; Female; Human T-lymphotropic virus 1; Humans; Male; Middle Aged; Muscular Diseases; Paraparesi | 2015 |
Human T-lymphotropic virus type-I (HTLV-I)-associated myelopathy with bulbar palsy-type amyotrophic lateral sclerosis-like symptoms.
Topics: Amyotrophic Lateral Sclerosis; Anti-Inflammatory Agents; Biomarkers; Bulbar Palsy, Progressive; Fema | 2015 |
Triple Therapy with Prednisolone, Pegylated Interferon and Sodium Valproate Improves Clinical Outcome and Reduces Human T-Cell Leukemia Virus Type 1 (HTLV-1) Proviral Load, Tax and HBZ mRNA Expression in Patients with HTLV-1-Associated Myelopathy/Tropical
Topics: Adult; Anti-Inflammatory Agents; Basic-Leucine Zipper Transcription Factors; Cross-Sectional Studies | 2015 |
Fulminant myelopathy following neurogenic proximal weakness associated with human T-cell lymphotropic virus type I infection.
Topics: Aged; Glucocorticoids; Humans; Magnetic Resonance Imaging; Male; Muscle Weakness; Muscular Atrophy; | 2011 |
HTLV-I positive progressive spastic paraparesis (TSP) associated with a lymphoid disorder in three Chilean patients.
Topics: Adult; Antibodies, Viral; Antigens, CD; Blotting, Southern; Dermatitis, Exfoliative; Female; Humans; | 1995 |
Development of Graves' ophthalmopathy and uveitis after radioiodine therapy for Graves' disease in a patient with HTLV-I associated myelopathy (HAM).
Topics: Adult; Exophthalmos; Eye Diseases; Female; Glaucoma; Graves Disease; Humans; Iodine Radioisotopes; P | 1994 |
Human T-cell lymphotropic virus type-I associated myelopathy complicated by optic neuritis.
Topics: Anti-Inflammatory Agents; Dexamethasone; Female; HTLV-I Antibodies; Humans; Middle Aged; Optic Neuri | 1996 |
Recent studies on the epidemiology, clinical features and pathogenic mechanisms of HTLV-I associated myelopathy (HAM/TSP) and other diseases associated to HTLV.
Topics: Blood Component Removal; Blood-Brain Barrier; Brain; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymp | 1997 |
Alteration of cytokine levels by fosfomycin and prednisolone in spontaneous proliferation of cultured lymphocytes from patients with HTLV-I-associated myelopathy (HAM/TSP).
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Cells, Cultured; Culture Media; Cytoki | 1997 |
[Spastic paraparesis and sensory disturbance improved by prednisolone therapy].
Topics: Aged; Humans; Male; Nervous System Diseases; Paraparesis, Tropical Spastic; Prednisolone; Sensation | 1992 |
[The clinical features of HTLV-I infection. HTLV-I associated myelopathy].
Topics: Aged; Female; HTLV-I Antibodies; Humans; Interferon-alpha; Male; Middle Aged; Paraparesis, Tropical | 1992 |
[HTLV-I-associated myelopathy].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azathioprine; Child; Female; HTLV-I Antibodies; Humans; | 1992 |
Leukoencephalopathy in HTLV-I-associated myelopathy/tropical spastic paraparesis: MRI analysis and a two year follow-up study after corticosteroid therapy.
Topics: Age Factors; Brain; Follow-Up Studies; HTLV-I Antibodies; HTLV-I Infections; Human T-lymphotropic vi | 1991 |
Plasmapheresis to treat human T lymphotropic virus type I-associated myelopathy.
Topics: Adult; Aged; Combined Modality Therapy; Cyclophosphamide; Evaluation Studies as Topic; Female; Follo | 1990 |
[Diagnosis and treatment of HTLV-I associated myelopathy].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Transfusion; Child; Female; Genes, Viral; Human T- | 1990 |
[HTLV-I-associated myelopathy (HAM)].
Topics: Adolescent; Adult; Aged; Blood Transfusion; Child; Humans; Japan; Middle Aged; Paraparesis, Tropical | 1990 |
[Efficacy of leukocytapheresis and low-dose prednisolone treatment in a patient with HTLV-I-associated myelopathy (HAM)].
Topics: Administration, Oral; Aged; Female; Humans; Leukapheresis; Paraparesis, Tropical Spastic; Prednisolo | 1990 |
[HAM (HTLV-I associated myelopathy)].
Topics: Blood Transfusion; Humans; Japan; Paraparesis, Tropical Spastic; Plasma Exchange; Prednisolone | 1989 |